Development of characterization methods for entacapone in a pharmaceutical bulk
Authors:
- Nadejda SoukhovaNSNadejda Soukhova
- Zarema KassymbekZKZarema Kassymbek
- Sanford BradbySBSanford Bradby
- Amanda Martin-EskerAMAmanda Martin-Esker
- Patricia WhitePWPatricia White
- Samir WahabSWSamir Wahab
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 54 (4) , 860-865
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Stress Degradation Behavior of Entacapone and Development of LC Stability-Indicating Related Substances and Assay MethodChromatographia, 2009
- Stability-Indication LC Determination of Entacapone in TabletsChromatographia, 2007
- High-performance liquid chromatography method for the quantification of entacapone in human plasmaJournal of Chromatography B, 2005
- Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT InhibitorsPharmacological Reviews, 1999
- Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dogEuropean Journal of Drug Metabolism and Pharmacokinetics, 1993
- Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.Drug Metabolism and Disposition, 1993
- Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urineJournal of Pharmaceutical and Biomedical Analysis, 1992